Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL17P37 (ribosomal protein L17 pseudogene 37) is a human processed pseudogene related to the functional RPL17 gene, which encodes a component of the 60S ribosomal subunit[7]. Pseudogenes are genomic DNA sequences similar to normal genes but nonfunctional; they often arise by duplication and retrotransposition[5]. RPL17P37 does not encode a functional protein and is not known to possess a biological or therapeutic function. Its presence is typical within the ribosomal protein gene family, many of which have multiple pseudogenes dispersed throughout the genome[1][3][5]. There is no clinical, diagnostic, or therapeutic relevance recorded for RPL17P37.\n\nThis entry is an example of a genomic pseudogene, and not a biological or drug discovery target. If your interest is in **ribosomal protein L17** (RPL17), that functional protein does participate in ribosome-mediated protein synthesis and is linked to some disease states when mutated (e.g., macrocytic anemia)[1][3], but its pseudogenes—including RPL17P37—do not have direct clinical or biological importance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ribosomal protein L17 pseudogene 37 (RPL17P37).